Journal of Oncology / 2009 / Article / Tab 1

Research Article

A Population-Based Clinical Trial of Irinotecan and Carboplatin

Table 1

Schema of dose levels for irinotecan and carboplatin.

Dose levelIrinotecan (mg/ )Carboplatin AUC

11004
21005
31505
42005
52505
62506
73006
83506

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.